Growth Metrics

Allurion Technologies (ALURW) EBITDA Margin (2022 - 2026)

Allurion Technologies posted quarterly EBITDA Margin of 126.6% for Q1 2026, up 390.0% year-on-year from 25.84% in Q1 2025, and up 27.32% on a QoQ basis from 174.2% in Q4 2025.

Allurion Technologies (ALURW) has 5 years of EBITDA Margin data on file, last reported at 126.6% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin rose 390.0% year-over-year to 126.6%; the trailing twelve-month figure through Mar 2026 stood at 211.22% (down 4840.0% YoY), and the FY2025 full-year result was 198.01%, down 4168.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 126.6%, up from 174.2% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 26.42% in Q2 2022 and bottomed at 362.3% in Q3 2025.
  • The 5-year median for EBITDA Margin is 128.55% (2026), against an average of 159.26%.
  • The widest annual swing landed in 2023, when EBITDA Margin sank 26013 bps; it then surged 13191 bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 52.9% in 2022, then tumbled by 492 bps to 313.03% in 2023, then climbed by 2 bps to 306.12% in 2024, then jumped by 43 bps to 174.2% in 2025, then gained by 27 bps to 126.6% in 2026.
  • The last three EBITDA Margin figures came in at 126.6% (Q1 2026), 174.2% (Q4 2025), and 362.3% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Allurion Technologies - - 1.23 Mn -126.60%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -126.60%
Dec 31, 2025 -173.18%
Sep 30, 2025 -362.30%
Jun 30, 2025 -205.74%
Mar 31, 2025 -130.82%
Dec 31, 2024 -305.81%
Sep 30, 2024 -229.94%
Jun 30, 2024 -79.43%
Mar 31, 2024 -121.46%
Dec 31, 2023 -312.54%
Sep 30, 2023 -143.70%
Jun 30, 2023 -102.58%
Mar 31, 2023 -98.78%
Dec 31, 2022 -52.90%
Sep 30, 2022 -74.61%
Jun 30, 2022 -26.42%